BlackRock Investment Management’s Utah Medical Products UTMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$1.03M Sell
14,185
-61
-0.4% -$3.97K ﹤0.01% 2678
2016
Q3
$852K Sell
14,246
-29
-0.2% -$1.84K ﹤0.01% 2769
2016
Q2
$899K Buy
14,275
+465
+3% +$30K ﹤0.01% 2707
2016
Q1
$864K Buy
13,810
+38
+0.3% +$2.24K ﹤0.01% 2583
2015
Q4
$806K Sell
13,772
-277
-2% -$15.7K ﹤0.01% 2745
2015
Q3
$757K Buy
14,049
+227
+2% +$12.4K ﹤0.01% 2805
2015
Q2
$824K Buy
13,822
+2,745
+25% +$155K ﹤0.01% 2910
2015
Q1
$663K Buy
11,077
+284
+3% +$16.7K ﹤0.01% 2806
2014
Q4
$648K Buy
10,793
+14
+0.1% +$775 ﹤0.01% 2844
2014
Q3
$526K Buy
10,779
+344
+3% +$17.5K ﹤0.01% 2942
2014
Q2
$537K Buy
10,435
+1,311
+14% +$67.3K ﹤0.01% 3009
2014
Q1
$528K Buy
9,124
+92
+1% +$5.02K ﹤0.01% 2929
2013
Q4
$516K Sell
9,032
-207
-2% -$11.4K ﹤0.01% 2932
2013
Q3
$549K Buy
9,239
+320
+4% +$17.5K ﹤0.01% 2866
2013
Q2
$484K Buy
+8,919
New +$420K ﹤0.01% 2867

Other funds holding UTMD

BlackRock Investment Management's UTMD Position: Q4 2016 in Review

BlackRock Investment Management reduced its Utah Medical Products (UTMD) stake by 0.43% in Q4 2016, selling an estimated $3.97K and leaving 14,185 shares worth $1.03M. The position accounts for ﹤0.01% of the portfolio, ranked #2678.

BlackRock Investment Management first reported a position in UTMD in Q2 2013 and has held it in 15 quarters since. 75 funds tracked by Wall St. Rank hold UTMD as of Q4 2016.

  • BlackRock Investment Management held 14,185 shares of Utah Medical Products worth $1.03M as of Q4 2016.
  • BlackRock Investment Management sold 61 Utah Medical Products shares in Q4 2016, an estimated $3.97K.
  • Utah Medical Products made up ﹤0.01% of BlackRock Investment Management's portfolio in Q4 2016, its #2678 holding.
  • BlackRock Investment Management first reported a position in Utah Medical Products in Q2 2013 and has held it in 15 quarters since.
  • 75 funds tracked by Wall St. Rank held Utah Medical Products as of Q4 2016.

Based on BlackRock Investment Management's 13F filing for Q4 2016, filed 10 Feb 2017.